L'Allogreffe de Cellules Souches Hématopoïétiques a changé le pronostic des enfants atteints de Leucémie Aigüe. Cependant, la stratégie thérapeutique après rechute post allogreffe reste mal définie. Nous avons cherché à comparer les stratégies thérapeutiques chez 334 enfants atteints de leucémie aigüe après échec d'allogreffe sur une période...
-
June 28, 2016 (v1)PublicationUploaded on: March 26, 2023
-
December 11, 2018 (v1)Publication
The mesenchymal stromal cells (MSCs) present many features that render attractive as therapeutic cells. Their phenotype, multipotency and immunosuppressive properties are well described. Nevertheless, major restriction for their clinical use is due to the limited in vitro expansion and low quantity of cells that can be collected from adult...
Uploaded on: December 4, 2022 -
January 25, 2018 (v1)Journal article
International audience
Uploaded on: December 4, 2022 -
October 24, 2013 (v1)Journal article
International audience
Uploaded on: December 3, 2022 -
October 24, 2013 (v1)Journal article
International audience
Uploaded on: October 11, 2023